Evogene (EVGN) Earnings Date, Estimates & Call Transcripts

$4.14

+0.16 (+4.02%)

(As of 09:34 AM ET)

Latest Earnings Date: Aug. 22Confirmed

Conference Call Audio

EVGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EVGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

Elon to Transform U.S. Economy?

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

EVGN Earnings Date and Information

Evogene last released its quarterly earnings results on August 22nd, 2024. The biotechnology company reported $0.00 earnings per share (EPS) for the quarter. Evogene has generated ($0.46) earnings per share over the last year (($0.46) diluted earnings per share). Evogene has confirmed that its next quarterly earnings report will be published on Thursday, August 22nd, 2024. Evogene will be holding an earnings conference call on Thursday, August 22nd at 9:00 AM Eastern. Interested parties can register for or listen to the call..

Evogene Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/22/2024 (Confirmed)	-	-	-	-	-	-	-
5/23/2024	Q1 2024	-	($0.80)	($0.80)	($0.08)	-	$4.19 million
3/7/2024	Q4 2023	($1.40)	($1.30)	+$0.10	($0.13)	$1.73 million	$0.58 million
11/15/2023	Q3 2023	($1.70)	($0.80)	+$0.90	($0.08)	$1.09 million	$3.77 million
8/17/2023	Q2 2023	($1.90)	($1.70)	+$0.20	($0.17)	$0.77 million	$0.65 million
5/18/2023	Q1 2023	($1.60)	($1.50)	+$0.10	($0.15)	$0.87 million	$0.64 million
3/9/2023	Q4 2022	($2.10)	($0.70)	+$1.40	($0.07)	$0.55 million	$0.66 million
Get the Latest News and Ratings for EVGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter.
11/17/2022	Q3 2022	($2.00)	($1.60)	+$0.40	($0.16)	$0.26 million	$0.47 million
8/31/2022	Q2 2022	($1.80)	($2.10)	($0.30)	($0.21)	$0.17 million	$0.31 million
5/26/2022	Q1 2022	($1.40)	($2.00)	($0.60)	($0.20)	$0.44 million	$0.24 million
3/10/2022	Q4 2021	($2.00)	($1.80)	+$0.20	($0.18)	$0.15 million	$0.31 million
11/16/2021	Q3 2021	($1.70)	($1.90)	($0.20)	($0.19)	$0.14 million	$0.15 million
8/11/2021	Q2 2021	($1.80)	($1.50)	+$0.30	($0.15)	-	$0.14 million
5/25/2021	Q1 2021	($1.80)	($1.70)	+$0.10	($0.17)	-	$0.33 million
3/2/2021	Q4	($1.70)	($2.50)	($0.80)	($0.25)	-	$0.35 million
11/18/2020	Q3 2020	-	($1.70)	($1.70)	($0.17)	-	$0.32 million
8/5/2020	Q2 2020	-	($1.60)	($1.60)	($0.16)	-	$0.30 million
5/26/2020	Q1 2020	-	($2.40)	($2.40)	($0.24)	-	$0.08 million
3/4/2020	Q4 2019	-	($2.40)	($2.40)	($0.24)	-	$0.12 million
11/13/2019	Q3 2019	-	($1.60)	($1.60)	($0.16)	-	$0.10 million

Evogene Earnings - Frequently Asked Questions

When is Evogene's earnings date?: Evogene has confirmed that its next quarterly earnings data will be published on Thursday, August 22nd, 2024. Learn more on EVGN's earnings history.
How can I listen to Evogene's earnings conference call?: The conference call for Evogene's latest earnings report can be listened to online. Listen to Conference Call
How much revenue does Evogene generate each year?: Evogene (NASDAQ:EVGN) has a recorded annual revenue of $9.19 million.
How much profit does Evogene generate each year?: Evogene (NASDAQ:EVGN) has a recorded net income of -$23.88 million. EVGN has generated -$0.46 earnings per share over the last four quarters.